Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 101624, 10 pages
http://dx.doi.org/10.1155/2014/101624
Research Article

Gastrodia elata Ameliorates High-Fructose Diet-Induced Lipid Metabolism and Endothelial Dysfunction

1College of Oriental Medicine and Professional Graduate School of Oriental Medicine, Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570-749, Republic of Korea
2Hanbang Body-Fluid Research Center, Wonkwang University, Shinyong-dong, Iksan, Jeonbuk 570-749, Republic of Korea
3Department of Research Development, Institute of Jinan Red Ginseng, Jinan, Jeonbuk 567-801, Republic of Korea

Received 13 November 2013; Accepted 27 December 2013; Published 26 February 2014

Academic Editor: Waris Qidwai

Copyright © 2014 Min Chul Kho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. M. Egan, E. L. Greene, and T. L. Goodfriend, “Insulin resistance and cardiovascular disease,” The American Journal of Hypertension, vol. 14, no. 6, pp. S116–S125, 2001. View at Google Scholar · View at Scopus
  2. S. M. Grundy, “Obesity, metabolic syndrome, and coronary atherosclerosis,” Circulation, vol. 105, no. 23, pp. 2696–2698, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. K. L. Stanhope and P. J. Havel, “Fructose consumption: recent results and their potential implications,” Annals of the New York Academy of Sciences, vol. 1190, pp. 15–24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Basciano, L. Federico, and K. Adeli, “Fructose, insulin resistance, and metabolic dyslipidemia,” Nutrition and Metabolism, vol. 2, article 5, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Y. Kim, T. Okubo, L. R. Juneja, and T. Yokozawa, “The protective role of amla (Emblica officinalis Gaertn.) against fructose-induced metabolic syndrome in a rat model,” British Journal of Nutrition, vol. 103, no. 4, pp. 502–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Ouyang, P. Cirillo, Y. Sautin et al., “Fructose consumption as a risk factor for non-alcoholic fatty liver disease,” Journal of Hepatology, vol. 48, no. 6, pp. 993–999, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. K. Panchal and L. Brown, “Rodent models for metabolic syndrome research,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 351982, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Ferder, M. D. Ferder, and F. Inserra, “The role of high-fructose corn syrup in metabolic syndrome and hypertension,” Current Hypertension Reports, vol. 12, no. 2, pp. 105–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Tang and G. Eisenbrand, Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine, Springer, Berlin, Germany, 1992.
  10. C.-S. Ding, Y.-S. Shen, G. Li, Z. Wei, and F. Wei, “Study of a glycoprotein from Gastrodia elata: its effects of anticoagulation and antithrombosis,” Zhongguo Zhongyao Zazhi, vol. 32, no. 11, pp. 1060–1064, 2007. View at Google Scholar · View at Scopus
  11. M. Musharof Hossain, “Therapeutic orchids: traditional uses and recent advances: an overview,” Fitoterapia, vol. 82, no. 2, pp. 102–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J.-H. Ha, S.-M. Shin, S.-K. Lee et al., “In vitro effects of hydroxybenzaldehydes from Gastrodia elata and their analogues on GABAergic neurotransmission, and a structure-activity correlation,” Planta Medica, vol. 67, no. 9, pp. 877–880, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. J. Lee, S. M. Hwang, D. G. Kang, J. S. Kim, and H. S. Lee, “Effect of Gastrodia elata on tumor necrosis factor-alpha-induced matrix metalloproteinase activity in endothelial cells,” Journal of Natural Medicines, vol. 63, no. 4, pp. 463–467, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Hwang, Y. J. Lee, D. G. Kang, and H. S. Lee, “Anti-inflammatory effect of Gastrodia elata rhizome in human umbilical vein endothelial cells,” The American Journal of Chinese Medicine, vol. 37, no. 2, pp. 395–406, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Tilg and G. S. Hotamisligil, “Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance,” Gastroenterology, vol. 131, no. 3, pp. 934–945, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. G. L. Kelley, G. Allan, and S. Azhar, “High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation,” Endocrinology, vol. 145, no. 2, pp. 548–555, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. Miatello, M. Vázquez, N. Renna, M. Cruzado, A. P. Zumino, and N. Risler, “Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats,” The American Journal of Hypertension, vol. 18, no. 6, pp. 864–870, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. N. F. Renna, M. A. Vazquez, M. C. Lama, E. S. González, and R. M. Miatello, “Effect of chronic aspirin administration on an experimental model of metabolic syndrome,” Clinical and Experimental Pharmacology and Physiology, vol. 36, no. 2, pp. 162–168, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Miller and K. Adeli, “Dietary fructose and the metabolic syndrome,” Current Opinion in Gastroenterology, vol. 24, no. 2, pp. 204–209, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. L. T. Tran, V. G. Yuen, and J. H. McNeill, “The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension,” Molecular and Cellular Biochemistry, vol. 332, no. 1-2, pp. 145–159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Suzuki and H. Hara, “Ingestion of guar gum hydrolysate, a soluble and fermentable nondigestible saccharide, improves glucose intolerance and prevents hypertriglyceridemia in rats fed fructose,” Journal of Nutrition, vol. 134, no. 8, pp. 1942–1947, 2004. View at Google Scholar · View at Scopus
  22. K. M. Rexrode, J. E. Manson, and C. H. Hennekens, “Obesity and cardiovascular disease,” Current Opinion in Cardiology, vol. 11, no. 5, pp. 490–495, 1996. View at Google Scholar · View at Scopus
  23. C. J. Pepine, “Clinical implications of endothelial dysfunction,” Clinical Cardiology, vol. 21, no. 11, pp. 795–799, 1998. View at Google Scholar · View at Scopus
  24. K. Tziomalos, V. G. Athyros, A. Karagiannis, and D. P. Mikhailidis, “Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 2, pp. 140–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Z. Chun, X. Xu, Y. Cui et al., “Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats,” Journal of Pharmacology and Experimental Therapeutics, vol. 328, no. 2, pp. 610–620, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. F. Mahmoud, M. El-Nagar, and H. M. El-Bassossy, “Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats,” Archives of Pharmacal Research, vol. 35, no. 1, pp. 155–162, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. D. H. Endemann and E. L. Schiffrin, “Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus,” Current Hypertension Reports, vol. 6, no. 2, pp. 85–89, 2004. View at Google Scholar · View at Scopus
  28. W. J. Lee, K. L. In, S. K. Hyoun et al., “α-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2488–2494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Luo, A. K. Saha, X. Xiang, and N. B. Ruderman, “AMPK, the metabolic syndrome and cancer,” Trends in Pharmacological Sciences, vol. 26, no. 2, pp. 69–76, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. B. Majithiya and R. Balaraman, “Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats,” Life Sciences, vol. 78, no. 22, pp. 2615–2624, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Misra and R. Chakrabarti, “The role of AMP kinase in diabetes,” Indian Journal of Medical Research, vol. 125, no. 3, pp. 389–398, 2007. View at Google Scholar · View at Scopus
  32. P. Misra, “AMP activated protein kinase: a next generation target for total metabolic control,” Expert Opinion on Therapeutic Targets, vol. 12, no. 1, pp. 91–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Zhang, T.-S. Lee, E. M. Kolb et al., “AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 6, pp. 1281–1287, 2006. View at Publisher · View at Google Scholar · View at Scopus